Alaunos Therapeutics | ZIOP - Net Income


Alaunos Therapeutics reported $-1.01M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Alaunos Therapeutics USD -1.01M 153K Mar/2026
Amgen USD 1.82B 486M Mar/2026
AstraZeneca USD 3.08B 754M Mar/2026
Baxter International USD -15M 1.11B Mar/2026
Biogen USD 319.5M 368.4M Mar/2026
Bioline Rx USD -1.6M 635K Mar/2026
Bristol-Myers Squibb USD 2.68B 1.59B Mar/2026
Celltrion KRW 8.82B 64.74M Mar/2026
Corcept Therapeutics USD -31.76M 56.05M Mar/2026
Cspc Pharmaceutical CNY 370.72M 592.81M Dec/2025
Curis USD 19.36M 31.16M Dec/2025
Deva Holding AS TRY 583.98M 319.1M Sep/2023
Dianthus Therapeutics USD -40.83M 23.6M Mar/2026
Divis Laboratories Ltd INR 7.51B 1.68B Mar/2026
Gilead Sciences USD 2.02B 162M Mar/2026
GlaxoSmithKline GBP 1.74B 1.1B Mar/2026
Incyte USD 303.33M 4.05M Mar/2026
Ionis Pharmaceuticals USD -93M 136M Mar/2026
J&J USD 5.53B 299M Jun/2026
Kangmei Pharma CNY -16.56M 12.74M Mar/2026
Karyopharm Therapeutics USD -102.2M 71.42M Dec/2025
Knight Therapeutics CAD -3.79M 8.83M Sep/2025
Laboratorios Farma EUR 103.69M 37.04M Dec/2023
Malin Corporation EUR -1.1M 2.2M Dec/2023
Medical Developments International AUD -226K 121K Dec/2025
Merck USD -4.24B 7.2B Mar/2026
Neuren Pharmaceuticals AUD 15.4M 7.88M Dec/2025
Novartis USD 3.16B 747M Mar/2026
Organigram Holdings CAD -921K 20.89M Mar/2026
Ovoca Bio EUR -765K 4.89M Jun/2025
Pfizer USD 2.69B 4.34B Mar/2026
Pharma Mar EUR 1.53M 58.13M Mar/2026
PTC Therapeutics USD -2.81M 132.16M Mar/2026
Qiagen NV USD 107.83M 22.21M Dec/2025
Regeneron Pharmaceuticals USD 727.2M 117.4M Mar/2026
Roche Holding CHF 5.47B 1.76B Dec/2025
Sangamo BioSciences USD -36.13M 12.96M Jun/2024
Sartorius EUR 56.2M 37M Mar/2026
Sino Biopharmaceutical CNY 3.39B 2.91B Jun/2025
TG Therapeutics USD 19.78M 3.26M Mar/2026
Tilray USD -44.93M 44.61M Sep/2025
Verastem USD -32.92M 24.66M Dec/2025
Zealand Pharma A/S -379.12M 25.12M Dec/2025
Zz Pientze Pharmaceu CNY 743.48M 56.45M Mar/2026